STYLE: Stepping back — and down — into Cold War paranoia. Behind Craig Denham’s midcentury modern house in West Lake Hills is a large metal door set at an angle. Down the steep concrete steps embedded in solid limestone one enters an enclosed world almost untouched for 50 years. Denham, an Atomic Age aficionado, lucked into a mint-condition fallout shelter, complete with powdered food, geiger counter, shortwave radio and all one would need to survive two weeks, when the radioactive dust of a nuclear explosion supposedly subsides. The story of the shelter’s origins — plus the discovery of a short public service film about what to do if Austin were hit — will make a great feature. (Look for it soon in the Statesman.)

CITY: Finished up my research on St. John’s Orphan Home. A homeowner in the Highland neighborhood casually told me — when we were tracing the origins of Waller Creek in her area — that an African American orphanage once stood where Highland Mall/ACC now rises. It took more than a year of spotty research to pin down the history of the St. John’s Regular Baptist Association, its encampments and schools, as well as the residential districts — Highland, St. John, University Hills — that were carved from the 350-acre farm. The only missing element: An interview with current association moderator Rev. G.V. Clark. (Still holding out hope …)

MEDIA: The charming couple behind "Miss Wanda and I." This double profile appeared today in the Statesman. "On April 19, 1995 — the day of the Oklahoma City bombing — David Phillips ran into Wanda Hannah at Borders bookstore in Houston. The acquaintances discovered they were both single. Tall, expansive book salesman Phillips, now 69, had wed three times previously. Shorter, shy librarian Hannah, now 77, already had tied the knot twice. "After 19 years of marriage, Hannah said she didn’t want to be married any more," Phillips says. "Still, I got her phone number." Over dinner at upscale Vargo’s, Phillips reached over and took Hannah’s hand. "I don’t know if you are seeing anyone," he said. "But I let you get away from me 20 years ago, and I’m not going to let it happen a second time." "When he said that, I lost my appetite," Hannah says. "I took the rest of my dinner home." http://shar.es/iinKY(A sheer delight to report.)

MUSIC: Johnny Ray Watson’s joyful noise. Reported by Marty Toohey in the Statesman. "The auditorium was dark and modest for a man whose performances were once seen by millions of people. Yet there sat Johnny Ray Watson on a stool under the spotlight, smiling and waving, and there sat about 200 listeners on long wooden pews, waiting in quiet anticipation. ‘It’s his personality,’ said Mike Robertson, a longtime fan. ‘It beams out of him like a spotlight … he never does it halfway.’ Slowly, the gospel singer unfolded his 6-foot-7 frame and rose. His eyes met the eyes of the churchgoers, whom he affectionately called his "vanilla brothers and sisters." But their faces were getting harder to discern. After 63 years — after a career spent looking into the eyes of audiences in tiny Panhandle churches, in prisons across the nation, in venues as far-flung as Japan and Jamaica and South Africa — Watson’s right eye had all but failed." http://shar.es/iinpr(Now this is a Sunday feature to linger over.)

CHARITY: These stories just break your heart while giving you a glimmer of hope. " Reported by Andrea Ball in the Statesman: "Andrea Sloan had no idea that volunteering to be a guinea pig for a new cancer drug would be so hard. Her doctor had signed off on it. The Food and Drug Administration was on board. Sloan was willing to risk the unknown for a chance to stave off her progressing ovarian cancer. But what the Austin woman discovered was a complicated, arbitrary process that puts the future of desperately ill people into the hands of pharmaceutical companies. Since mid-August, Sloan has been waging a social media campaign to persuade BioMarin Pharmaceutical to give her access to BMN 673, an investigational medication with an early success rate the company recently touted to investors. But BioMarin won’t give it to her. Company officials say that it has been tested on fewer than 30 people and that to provide it to everyone who wants it without additional research would be ‘unethical and reckless.’" http://shar.es/izLvW (Nobody reports like Andrea Ball.)